Prilenia Therapeutics has entered into a collaboration & license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets.

Inspired by the 2014 Ice Bucket Challenge, college students have revived the concept to promote mental health awareness. The ...

An Arizona man has become the third person in the world to receive Neuralink's brain implant - letting him 'speak' again in ...

The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other hand, the loss of function in certain kinases has been identified as a ...

A man with ALS received a Neuralink BCI implant, allowing him to control a laptop cursor and generate his own voice using AI.

Brad Smith, who is the first person with ALS and third to receive a Neuralink brain implant, shared his experience with the ...

Boston College baseball lost the third game of its series against Miami at Fenway Park on Sunday in the annual ALS Awareness ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

The Eagle-Tribune interviewed Charles “Chuck” Johnson and Nicole Johnson on April 11 for a story to show how the North ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don't know what causes it.

Advocates for patients with amyotrophic lateral sclerosis — a fatal condition known as Lou Gehrig’s disease — urged lawmakers ...